IMC Chicago
PRCT icon

IMC Chicago’s Procept Biorobotics PRCT Stock Holding History

IMC Chicago’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$975K Buy
39,000
+8,400
+27% +$237K ﹤0.01% 3315
2025
Q4 		$963K Sell
30,600
-23,700
-44% -$786K ﹤0.01% 3004
2025
Q3 		$1.94M Buy
54,300
+35,900
+195% +$1.64M ﹤0.01% 2248
2025
Q2 		$1.06M Sell
18,400
-8,200
-31% -$464K ﹤0.01% 2436
2025
Q1 		$1.55M Buy
26,600
+8,000
+43% +$546K ﹤0.01% 1967
2024
Q4 		$1.5M Buy
18,600
+3,500
+23% +$299K ﹤0.01% 2081
2024
Q3 		$1.21M Buy
+15,100
New +$1.07M ﹤0.01% 1957

Other funds holding PRCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

IMC Chicago's PRCT Position: Q1 2026 in Review

IMC Chicago increased its Procept Biorobotics (PRCT) stake by 62% in Q1 2026, buying an estimated $215K and bringing the position to 19,897 shares worth $498K. The position accounts for ﹤0.01% of the portfolio, ranked #4050.

IMC Chicago first reported a position in PRCT in Q4 2025 and has held it in 2 quarters since. 256 funds tracked by Wall St. Rank hold PRCT as of Q1 2026.

  • IMC Chicago held 19,897 shares of Procept Biorobotics worth $498K as of Q1 2026.
  • IMC Chicago bought 7,635 Procept Biorobotics shares in Q1 2026, an estimated $215K.
  • Procept Biorobotics made up ﹤0.01% of IMC Chicago's portfolio in Q1 2026, its #4050 holding.
  • IMC Chicago first reported a position in Procept Biorobotics in Q4 2025 and has held it in 2 quarters since.
  • 256 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.